VivoSeq
Nephrology

Renal Failure

1

Pipeline Programs

2

Active Trials

1

Companies Involved

Renal Failure is an early-stage landscape with 1 program across 1 company. The most active players are GSK. 1 program is in Phase 3.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

68/100

Attrition Rate

25/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Approved
No programs

Trial Status

32

clinical trials

Completed17 · 53%
Unknown status5 · 16%
Withdrawn4 · 13%
Terminated4 · 13%
Recruiting2 · 6%

Trial Activity

32 trials

Swedish Cardiac And Renal Failure Study-1
Recruiting·KKarolinska Institutet·Phase 2·NCT07029503·40 enrolled
May Metformin be Used in Renal Failure?
Completed··Phase 2·NCT02710448·82 enrolled
Fenoldopam and Acute Renal Failure
Completed·UUniversità Vita-Salute San Raffaele·Phase 3·NCT00621790·667 enrolled
Exercise Intolerance in Renal Failure
Completed·EEmory University·Phase 2·NCT01356966·74 enrolled
HBV Vaccine in Renal Failure Patients
Completed·TThe University of Hong Kong·Phase 2/3·NCT02621112·94 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)